SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,123.83 -125.56
( -0.17%)

Global Indices

Nasdaq

52,230.09 -658.89
(-1.25%)

Dow Jones

7,644.13 -40.30
(-0.52%)

Hang Seng

62,584.98 -322.86
(-0.51%)

Nikkei 225

10,670.63 -54.40
(-0.51%)

Forex

USD-INR

94.61 0.10
(0.11%)

EUR-INR

106.18 0.08
(0.07%)

GBP-INR

126.70 0.19
(0.15%)

JPY-INR

0.60 0.00
(0.70%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

18.604918

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

40.44

77.7

EPS(TTM)

Face Value()

Div & Yield %

1.26

Back

Dalmia Bharat Sugar & Industries consolidated net profit declines 80.34% in the June 2026 quarter

Aug 08,2026

Net profit of Dalmia Bharat Sugar & Industries declined 80.34% to Rs 7.72 crore in the quarter ended June 2026 as against Rs 39.26 crore during the previous quarter ended June 2025. Sales declined 9.85% to Rs 848.19 crore in the quarter ended June 2026 as against Rs 940.88 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	848.19	940.88	-10
OPM %	5.10	9.53	-
PBDT	44.23	84.68	-48
PBT	9.83	52.66	-81
NP	7.72	39.26	-80

73,123.83 -125.56 ( -0.17%)

52,230.09 -658.89 (-1.25%)

7,644.13 -40.30 (-0.52%)

62,584.98 -322.86 (-0.51%)

10,670.63 -54.40 (-0.51%)

94.61 0.10 (0.11%)

106.18 0.08 (0.07%)

126.70 0.19 (0.15%)

0.60 0.00 (0.70%)